142 related articles for article (PubMed ID: 3621185)
1. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.
Reibnegger G; Hetzel H; Fuchs D; Fuith LC; Hausen A; Werner ER; Wachter H
Cancer Res; 1987 Sep; 47(18):4977-81. PubMed ID: 3621185
[TBL] [Abstract][Full Text] [Related]
2. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix.
Reibnegger GJ; Bichler AH; Dapunt O; Fuchs DN; Fuith LC; Hausen A; Hetzel HM; Lutz H; Werner ER; Wachter H
Cancer Res; 1986 Feb; 46(2):950-5. PubMed ID: 3940654
[TBL] [Abstract][Full Text] [Related]
3. Preactivated T cells in cancer patients with poor prognosis.
Fuchs DN; Fuith LC; Hausen A; Hetzel H; Reibnegger GJ; Werner ER; Wachter H
Cancer Detect Prev; 1988; 12(1-6):97-103. PubMed ID: 3141055
[TBL] [Abstract][Full Text] [Related]
4. Neopterin and prognosis in patients with adenocarcinoma of the colon.
Weiss G; Kronberger P; Conrad F; Bodner E; Wachter H; Reibnegger G
Cancer Res; 1993 Jan; 53(2):260-5. PubMed ID: 8417818
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
[TBL] [Abstract][Full Text] [Related]
6. Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer.
Hetzel H; Bichler A; Fuchs D; Hausen A; Reibnegger G; Wachter H
Cancer Detect Prev; 1983; 6(1-2):263-6. PubMed ID: 6883385
[TBL] [Abstract][Full Text] [Related]
7. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease.
Reibnegger G; Fuchs D; Fuith LC; Hausen A; Werner ER; Werner-Felmayer G; Wachter H
Cancer Detect Prev; 1991; 15(6):483-90. PubMed ID: 1782638
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of nuclear roundness and neopterin in ovarian cancer.
Marth C; Weger A; Müller-Holzner E; Zeimet AG; Moncayo-Naveda H; Daxenbichler G; Reibnegger G; Fuchs D; Wachter H; Dapunt O
Eur J Cancer; 1993; 29A(13):1863-8. PubMed ID: 8260243
[TBL] [Abstract][Full Text] [Related]
9. [Role of the immune parameter neopterin in adnexitis].
Marth C; Windbichler G; Fuchs D; Zeimet AG; Wachter H; Dapunt O
Zentralbl Gynakol; 1996; 118(3):164-8. PubMed ID: 8900606
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of interleukin-6 and neopterin in patients with multiple myeloma.
Reibnegger G; Krainer M; Herold M; Ludwig H; Wachter H; Huber H
Cancer Res; 1991 Dec; 51(23 Pt 1):6250-3. PubMed ID: 1933885
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
12. The significance of neopterin determination as a tumour marker in ovarian cancer.
Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
[TBL] [Abstract][Full Text] [Related]
13. Levels of serum neopterin are increased in pancreatic cancer patients and correlate with the prognosis.
Birk D; Gansauge F; Gansauge S; Schwarz A; Beger HG
Eur J Med Res; 1999 Apr; 4(4):156-60. PubMed ID: 10205291
[TBL] [Abstract][Full Text] [Related]
14. Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases.
Hausen A; Bichler A; Fuchs D; Hetzel H; Reibnegger G; Wachter H
Cancer Detect Prev; 1985; 8(1-2):121-8. PubMed ID: 4064032
[TBL] [Abstract][Full Text] [Related]
15. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
16. [Initial experiences with the determination of neopterin in the urine of females with genital and breast tumors].
Bartel U; Rabe H; Schulz-Pinkus M
Zentralbl Gynakol; 1987; 109(20):1226-32. PubMed ID: 3425023
[TBL] [Abstract][Full Text] [Related]
17. Neopterin, a marker of cell-mediated immune activation in human pregnancy.
Fuith LC; Fuchs D; Hausen A; Hetzel H; Reibnegger G; Werner ER; Wachter H
Int J Fertil; 1991; 36(6):372-5. PubMed ID: 1684963
[TBL] [Abstract][Full Text] [Related]
18. Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patients.
Lissoni P; Barni S; Ardizzoia A; Scardino E; Tancini G; Viganò MG
J Biol Regul Homeost Agents; 1995; 9(1):21-3. PubMed ID: 8553904
[TBL] [Abstract][Full Text] [Related]
19. Neopterin excretion after liver transplantation and its value in differential diagnosis of complications.
Tilg H; Vogel W; Aulitzky WE; Schönitzer D; Margreiter R; Dietze O; Judmaier G; Wachter H; Huber C
Transplantation; 1989 Oct; 48(4):594-9. PubMed ID: 2552627
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer.
Baekelandt MM; Holm R; Nesland JM; Tropé CG; Kristensen GB
Anticancer Res; 2000; 20(2B):1061-7. PubMed ID: 10810398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
